CivicBeaconCivicBeacon
Health
HR5343
Senate
119th Congress

Ensuring Patient Access to Critical Breakthrough Products Act

Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.

Recent Activity

Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.

9/17/2025Committee

Committee Consideration and Mark-up Session Held

9/17/2025Committee

Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

9/15/2025IntroReferral

Viewing 3 of 6 actions

Get the full experience in the app

View more details and get real-time updates in the CivicBeacon app.

  • ✓Complete voting history
  • ✓Push notifications
  • ✓Save representatives
  • ✓Personal analytics (Premium)
Get the App

Sponsors

Rep. Moore, Blake D. [R-UT-1]

Rep. Moore, Blake D. [R-UT-1]

R - UT

Details

Introduced
9/15/2025